Increased transforming growth factor beta 1 expression mediates ozone-induced airway fibrosis in mice

References

• Arthur MJ. 1994. Degradation of matrix proteins in liver fibrosis. Pathol Res Pract 190: 825–833.
   PubMedGoogle Scholar
• Bellocq A, Azoulay E, Marullo S, Flahault A, Fouqueray B, Philippe C, Cadranel J, Baud L. 1999. Reactive oxygen and nitrogen intermediates increase transforming growth factor-beta1 release from human epithelial alveolar cells through two different mechanisms. Am J Respir Cell Mol Biol 21: 128–136.
   PubMed Web of Science ®Google Scholar
• Bergeron A, Soler P, Kambouchne M, Loiseau P, Milleron B, Valeyre D, Hance AJ, Tazi A. 2003. Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10. Eur Respir J 22: 69–76.
   PubMed Web of Science ®Google Scholar
• Bertozzi P, Astedt B, Zenzius L, Lynch K, LeMaire F, Zapol W, Chapman HA Jr. 1990. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 322: 890–897.
   PubMed Web of Science ®Google Scholar
• Bocci V, Luzzi E, Corradeschi F, Silvestri S. 1994. Studies on the biological effects of ozone: 6. Production of transforming growth factor 1 by human blood after ozone treatment. J Biol Regul Homeost Agents 8: 108–112.
   PubMed Web of Science ®Google Scholar
• Bonniaud P, Margetts PJ, Kolb M, Schroeder JA, Kapoun AM, Damm D, Murphy A, Chakravarty S, Dugar S, Higgins L, Protter AA, Gauldie J. 2005. Progressive Transforming Growth Factor {beta}1-induced Lung Fibrosis is Blocked by an orally Active ALK5 Kinase Inhibitor. Am J Respir Crit Care Med 171: 889–898.
   PubMed Web of Science ®Google Scholar
• Chang LY, Stockstill BL, Menache MG, Mercer RR, Crapo JD. 1995. Consequences of prolonged inhalation of ozone on F344/N rats: collaborative studies. Part VIII: Morphometric analysis of structural alterations in alveolar regions. Res Rep Health Eff Inst, 3-39; discussion 99.
   Google Scholar
• Chuang-Tsai S, Sisson TH, Hattori N, Tsai CG, Subbotina NM, Hanson KE, Simon RH. 2003. Reduction in fibrotic tissue formation in mice genetically deficient in plasminogen activator inhibitor-1. Am J Pathol 163: 445–452.
   PubMedGoogle Scholar
• Churg A, Zhou S, Preobrazhenska O, Tai H, Wang R, Wright JL. 2009. Expression of Profibrotic Mediators in Small Airways versus Parenchyma after Cigarette Smoke Exposure. Am J Respir Cell Mol Biol 40: 268–276.
   PubMed Web of Science ®Google Scholar
• Coker RK, Laurent GJ, Shahzeidi S, Lympany PA, du Bois RM, Jeffery PK, McAnulty RJ. 1997. Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol 150: 981–991.
   PubMed Web of Science ®Google Scholar
• Davidson JM. 1990. Biochemistry and turnover of lung interstitium. Eur Respir J 3: 1048–1063.
   PubMed Web of Science ®Google Scholar
• Dormans JA, van Bree L, Boere AJ, Marra M, Rombout PJ. 1999. Interspecies differences in time course of pulmonary toxicity following repeated exposure to ozone. Inhal Toxicol 11: 309–329.
   PubMed Web of Science ®Google Scholar
• Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, Simon RH. 1996. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97: 232–237.
   PubMed Web of Science ®Google Scholar
• Fahy RJ, Lichtenberger F, McKeegan CB, Nuovo GJ, Marsh CB, Wewers MD. 2003. The acute respiratory distress syndrome: a role for transforming growth factor-beta 1. Am J Respir Cell Mol Biol 28: 499–503.
   PubMed Web of Science ®Google Scholar
• Fanucchi MV, Buckpitt AR, Murphy ME, Plopper CG. 1997. Naphthalene cytotoxicity of differentiating Clara cells in neonatal mice. Toxicol Appl Pharmacol 144: 96–104.
   PubMed Web of Science ®Google Scholar
• Gunther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D, Temmesfeld-Wollbruck B, Seeger W. 2000a. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 161: 454–462.
   PubMed Web of Science ®Google Scholar
• Gunther A, Mosavi P, Ruppert C, Heinemann S, Temmesfeld B, Velcovsky HG, Morr H, Grimminger F, Walmrath D, Seeger W. 2000b. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease. Thromb Haemost 83: 853–860.
   PubMed Web of Science ®Google Scholar
• Hattori N, Degen JL, Sisson TH, Liu H, Moore BB, Pandrangi RG, Simon RH, Drew AF. 2000. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest 106: 1341–1350.
   PubMed Web of Science ®Google Scholar
• Higashiyama H, Yoshimoto D, Kaise T, Matsubara S, Fujiwara M, Kikkawa H, Asano S, Kinoshita M. 2007. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis. Exp Mol Pathol 83: 39–46.
   PubMed Web of Science ®Google Scholar
• Idell S, James KK, Levin EG, Schwartz BS, Manchanda N, Maunder RJ, Martin TR, McLarty J, Fair DS. 1989. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 84:695–705.
   PubMed Web of Science ®Google Scholar
• Kim JH, Song HY, Park JH, Yoon HJ, Park HG, Kim DK. 2010. IN-1233, an ALK-5 inhibitor: prevention of granulation tissue formation after bare metallic stent placement in a rat urethral model. Radiology 255: 75–82.
   PubMedGoogle Scholar
• Kolb M, Bonniaud P, Galt T, Sime PJ, Kelly MM, Margetts PJ, Gauldie J. 2002. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of “fibrosis-prone” and “fibrosis-resistant” mouse strains. Am J Respir Cell Mol Biol 27: 141–150.
   PubMed Web of Science ®Google Scholar
• Lang DS, Jorres RA, Mucke M, Siegfried W, Magnussen H. 1998. Interactions between human bronchoepithelial cells and lung fibroblasts after ozone exposure in vitro. Toxicol Lett 96-97: 13–24.
   PubMed Web of Science ®Google Scholar
• Last JA, Gelzleichter TR, Harkema J, Hawk S. 1994. Consequences of prolonged inhalation of ozone on Fischer-344/N rats: collaborative studies. Part I: Content and cross-linking of lung collagen. Res Rep Health Eff Inst 1-29; discussion 31-40.
   Google Scholar
• Last JA, Hesterberg TW, Reiser KM, Cross CE, Amis TC, Gunn C, Steffey EP, Grandy J, Henrickson R. 1981. Ozone-induced alterations in collagen metabolism of monkey lungs: use of biopsy-obtained lung tissue. Toxicol Appl Pharmacol 60: 579–585.
   PubMed Web of Science ®Google Scholar
• Last JA, Reiser KM, Tyler WS, Rucker RB. 1984. Long-term consequences of exposure to ozone. I. Lung collagen content. Toxicol Appl Pharmacol 72: 111–118.
   PubMed Web of Science ®Google Scholar
• Laurent GJ. 1987. Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol 252: C1–9
   PubMed Web of Science ®Google Scholar
• Lee CG, Cho SJ, Kang MJ, Chapoval SP, Lee PJ, Noble PW, Yehualaeshet T, Lu B, Flavell RA, Milbrandt J, Homer RJ, Elias JA. 2004. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med 200: 377–389.
   PubMed Web of Science ®Google Scholar
• Leonarduzzi G, Scavazza A, Biasi F, Chiarpotto E, Camandola S, Vogel S, Dargel R, Poli G. 1997. The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. Faseb J 11: 851–857.
   PubMed Web of Science ®Google Scholar
• Liu RM. 2008. Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis. Antioxid Redox Signal 10: 303–319.
   PubMed Web of Science ®Google Scholar
• Liu RM, Choi J, Wu JH, Gaston Pravia KA, Lewis KM, Brand JD, Mochel NS, Krzywanski DM, Lambeth JD, Hagood JS, Forman HJ, Thannickal VJ, Postlethwait EM. 2010. Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts. J Biol Chem 285:16239–16247.
   PubMedGoogle Scholar
• Long L, Crosby A, Yang X, Southwood M, Upton PD, Kim D-K, Morrell NW. 2009. Altered Bone Morphogenetic Protein and Transforming Growth Factor-{beta} Signaling in Rat Models of Pulmonary Hypertension: Potential for Activin Receptor-Like Kinase-5 Inhibition in Prevention and Progression of Disease. Circulation 119: 566–576.
   PubMed Web of Science ®Google Scholar
• Parks WC, Roby JD. 1994. Consequences of prolonged inhalation of ozone on F344/N rats: collaborative studies. Part IV: Effects on expression of extracellular matrix genes. Res Rep Health Eff Inst 3–20; discussion 21-29.
   PubMedGoogle Scholar
• Pickrell JA, Hahn FF, Rebar AH, Horoda RA, Henderson RF. 1987. Changes in collagen metabolism and proteinolysis after repeated inhalation exposure to ozone. Exp Mol Pathol 46: 159–167.
   PubMed Web of Science ®Google Scholar
• Reiser KM, Tyler WS, Hennessy SM, Dominguez JJ, Last JA. 1987. Long-term consequences of exposure to ozone. II. Structural alterations in lung collagen of monkeys. Toxicol Appl Pharmacol 89: 314–322.
   PubMed Web of Science ®Google Scholar
• Rube CE, Uthe D, Schmid KW, Richter KD, Wessel J, Schuck A, Willich N, Rube C. 2000. Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int J Radiat Oncol Biol Phys 47: 1033–1042.
   PubMed Web of Science ®Google Scholar
• Saito K, Ishizaka N, Aizawa T, Sata M, Iso-o N, Noiri E, Mori I, Ohno M, Nagai R. 2005. Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-beta1 in the heart. Am J Physiol Heart Circ Physiol 288: H1836–1843
   Google Scholar
• Shima M, Adachi M. 1991. [Changes of procoagulant and fibrinolytic activities in the alveoli of rats exposed to ozone]. Nippon Eiseigaku Zasshi 46: 724–733.
   PubMedGoogle Scholar
• Shvedova AA, Kisin ER, Murray AR, Kommineni C, Castranova V, Fadeel B, Kagan VE. 2008. Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes. Toxicol Appl Pharmacol 231: 235–240.
   PubMed Web of Science ®Google Scholar
• Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. 1997. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 100: 768–776.
   PubMed Web of Science ®Google Scholar
• Stockstill BL, Chang LY, Menache MG, Mellick PW, Mercer RR, Crapo JD. 1995. Bronchiolarized metaplasia and interstitial fibrosis in rat lungs chronically exposed to high ambient levels of ozone. Toxicol Appl Pharmacol 134: 251–263.
   PubMed Web of Science ®Google Scholar
• Sullivan DE, Ferris M, Pociask D, Brody AR. 2008. The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo. J Immunotoxicol 5: 145–149.
   PubMed Web of Science ®Google Scholar
• Sun JD, Pickrell JA, Harkema JR, McLaughlin SI, Hahn FF, Henderson RF. 1988. Effects of buthionine sulfoximine on the development of ozone-induced pulmonary fibrosis. Exp Mol Pathol 49: 254–266.
   PubMed Web of Science ®Google Scholar
• Tzortzaki EG, Antoniou KM, Zervo, MI, Lambiri I, Koutsopoulos A, Tzanakis N, Plataki M, Maltezakis G, Bouros D, Siafakas NM. 2007. Effects of antifibrotic agents on TGF-[beta]1, CTGF and IFN-[gamma] expression in patients with idiopathic pulmonary fibrosis. Respiratory Medicine 101: 1821–1829.
   PubMed Web of Science ®Google Scholar
• Valacchi G, Bocci V. 1999. Studies on the biological effects of ozone: 10. Release of factors from ozonated human platelets. Mediators Inflamm 8: 205–209.
   PubMed Web of Science ®Google Scholar
• van Bree L, Dormans JA, Boere AJ, Rombout PJ. 2001. Time study on development and repair of lung injury following ozone exposure in rats. Inhal Toxicol 13: 703–718.
   PubMed Web of Science ®Google Scholar
• Vayalil PK, Iles KE, Choi J, Yi A-K, Postlethwait EM, Liu R-M. 2007. Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter. Am J Physiol Lung Cell Mol Physiol 293:L1281–1292
   PubMed Web of Science ®Google Scholar
• Vayalil PK, Olman M, Murphy-Ullrich JE, Postlethwait EM, Liu RM. 2005. Glutathione restores collagen degradation in TGF-beta-treated fibroblasts by blocking plasminogen activator inhibitor-1 expression and activating plasminogen. Am J Physiol Lung Cell Mol Physiol 289: L937–945
   Google Scholar
• Vicencio AG, Lee CG, Cho SJ, Eickelberg O, Chuu Y, Haddad GG, Elias JA. 2004. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia? Am J Respir Cell Mol Biol 31: 650–656.
   PubMed Web of Science ®Google Scholar
• Williams AO, Flanders KC, Saffiotti U. 1993. Immunohistochemical localization of transforming growth factor-beta 1 in rats with experimental silicosis, alveolar type II hyperplasia, and lung cancer. Am J Pathol 142: 1831–1840.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Mann DM, Ruoslahti E. 1990. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346: 281–284.
   PubMed Web of Science ®Google Scholar
• Zhao W, Zhao T, Chen Y, Ahokas RA, Sun Y. 2008. Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Mol Cell Biochem 317: 43–50.
   PubMedGoogle Scholar